Stay updated on Cabozantinib in RAI-Refractory DTC Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in RAI-Refractory DTC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from “v3.5.2” to “v3.5.3,” reflecting a site release change rather than any alteration to the underlying study record details.
    Difference
    0.1%
    Check dated 2026-04-24T16:51:26.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:34:59.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-19T21:12:59.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The site revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:16:31.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 is displayed on the page, with no changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:21:32.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.1 instead of Revision: v3.4.0. This is a metadata update at the top of the page and does not affect study content.
    Difference
    0.1%
    Check dated 2026-02-04T22:49:26.000Z thumbnail image

Stay in the know with updates to Cabozantinib in RAI-Refractory DTC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RAI-Refractory DTC Clinical Trial page.